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Conclusions. These data suggest, to our knowledge for theLipoteichoic acid from Staphylococcus aureus reduces renal
first time, that LTA pretreatment for 24 hours significantlyischemia/reperfusion injury.
reduces renal I/R injury. We propose that the mechanism ofBackground. The aim of this study was to investigate
the protective effect involves reduction of the production ofwhether in vivo administration of a low, sub-lethal dose of
NO, ROS and peroxynitrite subsequent to reduced P-selectinlipoteichoic acid (LTA), a bacterial wall-fragment derived from
and iNOS expression and PMN recruitment. However, al-the Gram-positive bacterium Staphylococcus aureus, protects
though LTA pretreatment resulted in a reduction of iNOSthe kidney against the renal dysfunction and injury caused by
ischemia/reperfusion (I/R). expression and NO production, we hypothesize that the re-
Methods. Male Wistar rats were administered LTA from S. maining significant levels of NO contribute to the beneficial
aureus (1 mg/kg, IP). After 24 hours, rats were subjected to actions provided by LTA.
bilateral renal ischemia (45 min) followed by reperfusion (6 h).
Serum and urinary markers were measured for the assessment
of renal function, tubular and reperfusion-injury. Renal sec-
Renal ischemia is a major cause of acute renal failuretions were used for histological grading of renal injury and
for immunohistochemical localization of P-selectin, inducible (ARF), which despite significant advances in critical care
nitric oxide synthase (iNOS) and nitrotyrosine (indicative of medicine remains a major clinical problem, producing
peroxynitrite formation). Kidney myeloperoxidase (MPO) ac- grave morbidity and mortality that has not decreasedtivity and malondialdehyde (MDA) levels were measured for
significantly over the last 50 years [1, 2]. The prognosisassessment of polymorphonuclear (PMN) cell infiltration and
of ARF is complicated by the fact that reperfusion, al-lipid peroxidation, respectively. Nitric oxide (NO) production
was determined by measurement of plasma nitrite/nitrate though essential for the survival of ischemic renal tissue,
levels. causes additional damage (reperfusion-injury) [3]. Renal
Results. LTA pretreatment significantly reduced renal dys-
ischemia/reperfusion (I/R) also contributes to the con-function, tubular and reperfusion-injury caused by I/R of the
siderable morbidity associated with surgery and anesthe-kidney as well as histological evidence of renal injury. LTA
also reduced the expression of P-selectin and kidney MPO sia [4, 5] where renal dysfunction occurs in up to 50% of
activity associated with renal I/R. MDA levels were signifi- patients undergoing aortovascular surgery (for example,
cantly reduced by LTA pretreatment suggesting a reduction for supra- or juxtarenal abdominal aortic aneurysms) [5].in the lipid peroxidation and formation of reactive oxygen
Renal ischemia also occurs during renal transplantationspecies (ROS). LTA pretreatment also markedly reduced both
the expression of iNOS and the formation of nitrotyrosine (especially during organ retrieval and storage) and reper-
associated with renal I/R. Although LTA significantly reduced fusion-injury in the early transplant period is associated
plasma nitrite/nitrate levels associated with I/R, nitrite/nitrate with late allograft failure [6].levels remained at levels significantly higher than that mea-
Exposure of the kidney to sub-lethal ischemic, hyp-sured from the plasma obtained from Sham-operated animals.
oxic, thermal or chemical insults stimulate intrinsic
mechanisms that can protect the kidneys against a subse-
Key words: kidney transplantation, reperfusion-injury, Gram positive
quent insult, a phenomenon termed “preconditioning.”bacteria, lipopolysaccharide, P-selectin, inducible nitric oxide synthase,
nitric oxide, peroxynitrite. Generally, preconditioning of the kidney affords greater
protection against renal injury than most pharmacologi-Received for publication May 30, 2001
cal interventions [7]. Preconditioning of the kidney canand in revised form March 13, 2002
Accepted for publication May 10, 2002 be stimulated by several factors including brief periods
of sublethal ischemia (ischemic preconditioning) [8–11], 2002 by the International Society of Nephrology
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hypoxia [12] or heat (heat-shock preconditioning) [13]. or death in this species [33]. LTA has further advantages
Recently, “remote preconditioning” also has been de- over LPS in that (1) it localizes to the (mouse) kidney
scribed where ischemic preconditioning of the kidney after a 24 hour pretreatment and can be detected in
can protect against sustained renal I/R up to 15 days urine throughout the 48 hours after administration [34];
later [14] or against I/R injury in other remote organs (2) it does not induce iNOS in the rat kidney [35]; and
such as the heart [15]. Chemical preconditioning of the (3) it does not cause renal inflammation when adminis-
kidneys also can be induced by triggers including exoge- tered at doses as high as 15 mg/kg [36]. Although we
nous adenosine, low-dose cyclosporine, FK506 or sodium have recently shown that pretreatment of rats with LTA
arsenite [16–18]. Protection against subsequent renal I/R can protect against subsequent myocardial I/R injury
injury can be produced by administration of sublethal [37, 38], the ability of LTA to protect the kidney against
doses of lipopolysaccharide (LPS or endotoxin), a wall- I/R injury has not been investigated. Therefore, the aim
fragment of Gram-negative bacteria [19]. However, ad- of this study was to use an established in vivo rat model
ministration of LPS is problematic in that it can produce of renal I/R injury to investigate whether pretreatment
undesirable side effects due to the excessive generation with a low, sub-lethal dose of LTA (1 mg/kg) from S.
of pro-inflammatory cytokines [interleukin (IL)-1, tu- aureus could protect the kidney against subsequent I/R
mor necrosis factor (TNF)-], induction of pro-inflam- injury. Furthermore, the mechanism(s) by which LTA
matory genes such as inducible nitric oxide synthase reduces renal I/R injury was investigated and compared
(iNOS) and cyclooxygenase-2 (COX-2) and the release with that of LPS pretreatment.
of inflammatory mediators of cellular injury such as nitric
oxide (NO) and prostaglandins (PGs) [20]. Within the
METHODSkidney, LPS can mediate renal toxicity that contributes
to acute renal failure (ARF) [21]. Concerns regarding Experimental protocol
this toxicity have prompted the development of less toxic In vivo studies were carried out using 78 male Wistar
derivatives of LPS such as monophosphoryl lipid A rats (Tuck, Rayleigh, Essex, UK) weighing 212 to 337 g.
(MLA), which can provide protection against subse- Rats received a standard diet and water ad libitum and
quent I/R injury [22]. However, although better tolerated were cared for in accordance with both the Home Office
in humans [23], intravenous (IV) administration of MLA Guidance in the Operation of the Animals (Scientific Pro-
can still cause fever and the increased release of cyto-
cedures) Act 1986, published by Her Majesty’s Stationery
kines [24]. The recently developed synthetic structural
Office, London, U.K. and the Guiding Principles in the
analog of MLA, RC-552, also provides protection against
Care and Use of Animals published by the AmericanI/R injury but without eliciting fever or cytokine release
Physiological Society. Animals were randomly allocated[25]. The effects of MLA or RC-552 against renal I/R
into eleven groups.injury have not been investigated, although it is known
Sham Group. Rats were subjected to surgical proce-that an intraperitoneal (IP) dose of MLA (5 mg/kg)
dures except for renal I/R, and were maintained underadministered to rats localizes to the renal tubules and
anesthesia for the duration of the experiment (that is,medulla after 24 hours but is absent from the glomerulus
45 min  6 h, N  12).[26].
Control Group. Rats were subjected to surgical proce-Although Gram-positive organisms do not contain
dures and underwent renal ischemia for 45 minutes fol-LPS [27], Gram-positive bacteria can still cause septic
lowed by reperfusion for 6 hours (N  12).shock and multiple organ failure without causing endo-
1-hour SAL Group. Rats were administered salinetoxemia [28]. The cell wall of Gram-positive bacteria
(vehicle for LPS/LTA, 2 mL/kg IP) one hour prior tocontains lipoteichoic acid (LTA), which is a macroam-
renal I/R (N  6).phiphile equivalent to LPS in Gram-negative bacteria
1-hour LPS Group. Rats received LPS (1 mg/kg IP)[27]. Studies from this laboratory and others have pre-
one hour prior to renal I/R (N  6).viously demonstrated that LTA from Staphylococcus
1-hour LTA Group. Rats received LTA (1 mg/kg IP)aureus can cause a moderate induction of iNOS (and
one hour prior to renal I/R (N  6).subsequent NO production) via the activation of tyrosine
24-hour SAL Group. Rats were administered salinekinases and nuclear factor (NF)-B [29, 30] with a con-
(vehicle for LTA/LPS, 2 mL/kg IP) 24 hours prior tocomitant induction of GTP cyclohydrolase I and subse-
renal I/R (N  6).quent tetrahydrobiopterin synthesis [31]. Interestingly,
24-hour LPS Group. Rats received LPS (1 mg/kg IP)at higher concentrations, LTA also induces COX-2 ex-
24 hours prior to renal I/R (N  6).pression and PGE2 release via activation of NF-B in
24-hour LTA Group. Rats received LTA (1 mg/kghuman pulmonary epithelial cells [32]. LTA also causes
IP) 24 hours prior to renal I/R (N  6).a moderate hypotension in the rat, but unlike LPS and
S. aureus itself, it does not cause multiple organ failure 24-hour Tempol Group. Rats received a bolus of tem-
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pol (30 mg/kg IV) five minutes prior to reperfusion and Renal ischemia/reperfusion
30 mg/kg/h IV throughout reperfusion (N  6). As described previously, rats were subjected to bilat-
24-hour LPS  Tempol Group. Rats received LPS (1 eral renal occlusion for 45 minutes using non-traumatic
mg/kg IP) 24 hours prior to renal I/R followed by a bolus Dieffenbach artery clips to clamp the renal pedicles
of tempol (30 mg/kg IV) five minutes prior to reperfusion [41, 42]. Reperfusion commenced once the artery clips
and 30 mg/kg/h IV throughout reperfusion (N  6). were removed. Occlusion was verified visually by change
24-hour LTA  Tempol Group. Rats received LTA in the color of the kidneys to a paler shade, and reperfu-
(1 mg/kg IP) 24 hours prior to renal I/R followed by a sion by a blush. Rats subjected to sham-operation (Sham-
bolus of tempol (30 mg/kg IV) five minutes prior to operated) underwent identical surgical procedures to
reperfusion and 30 mg/kg/h IV throughout reperfusion Control rats, but were not subjected to bilateral renal
clamping and were maintained under anesthesia for the(N  6).
duration of the experiment. All groups described aboveRats allocated to the pretreatment groups were admin-
received a continuous infusion of 0.9% (wt/vol) salineistered an IP injection of one of the following, either 1
(2 mL/kg/h, IV) throughout the I/R period, and at theor 24 hours before commencement of renal I/R, after
end of all experiments rats were killed by an overdosewhich they were returned to cages and allowed free ac-
of sodium thiopentone.cess to rat chow and water: (1) LPS (1 mg/kg IP in 2
mL/kg saline); (2) LTA (1 mg/kg IP in 2 mL/kg saline);
Measurement of biochemical parametersor (3) saline (2 mL/kg IP; vehicle for LTA and LPS).
At the end of the reperfusion period, blood (1 mL)The time course and doses of LPS and LTA used were
samples were collected via the carotid artery into tubesbased on those previously shown by our group and others
containing serum gel. The samples were centrifugedto provide protection against subsequent I/R injury in
(6,000 r.p.m. for 3 min) to separate serum. All serumthe rat [37–40]. The protocol for tempol administration
samples were analyzed for biochemical parameters with-was based on that previously shown by us to significantly
in 24 hours after collection (Vetlab Services, Sussex,reduce renal I/R injury in the rat [41].
UK). Serum creatinine concentrations were used as an
indicator of renal function [41, 42]. Serum concentrationsAnimal surgery
of aspartate aminotransferase (AST), an enzyme locatedAll rats were anesthetized with sodium thiopentone
in the proximal tubule, was used as an indicator of reper-(Intraval Sodium, 120 mg/kg IP; Rhone Merieux Ltd.,
fusion-injury [41]. Urine samples were collected duringEssex, UK) and anesthesia was maintained by supple-
the reperfusion period and the volume of urine producedmentary IV bolii of sodium thiopentone as required.
recorded. Urine concentrations of Na were measured
Rats were prepared surgically for renal I/R as described
(Vetlab Services) at the end of the reperfusion period
previously [41, 42]. Briefly, anesthetized rats were placed
and used in conjunction with serum Na concentrations
onto a thermostatically controlled heating mat (Harvard to estimate fractional excretion of Na (FENa) using stan-Apparatus Ltd., Kent, UK) and body temperature main- dard formulae, and which was used as an indicator of
tained at 38  1C by means of a rectal probe attached tubular function [41, 42]. Concentrations of urinary N-ace-
to a homoeothermic blanket. A tracheotomy was per- tyl--d-glucosaminidase (NAG), a specific indicator of
formed to maintain airway patency and to facilitate tubular damage [41], was also measured (Clinica Medica
spontaneous respiration. The right carotid artery was e´ Diagno´stico Dr. Joaquim Chaves, Lisbon, Portugal)
cannulated and connected to a pressure transducer and used as a marker of tubular injury.
(Senso-Nor 840, Horten, Norway) for the measurement
of mean arterial blood pressure (MAP) and derivation Histological evaluation and scoring
of the heart rate (HR) from the pulse waveform, which Upon completion of experiments, kidneys were re-
were displayed on a data acquisition system (MacLab 8e, moved and fixed in 10% (wt/vol) formaldehyde, buffered
AD Instruments, Hastings, UK) installed on an Apple with phosphate buffered saline (PBS; 0.01 mol/L, pH
Macintosh computer. MAP and HR were monitored for 7.4). For histological evaluation and scoring, a 5 mm
the duration of each experiment. The jugular vein was section of kidney was removed and processed through
cannulated for the administration of saline or anesthesia to wax, after which 5 m sections were cut and stained
as required. A midline laparotomy was performed and with hematoxylin and eosin. Histological assessment of
the bladder was cannulated and allowed to drain freely tubular necrosis was determined semi-quantitatively us-
without leakage into the peritoneum. Both kidneys were ing a method modified from McWhinnie et al [43]. As
located and the renal pedicles, containing the artery, previously described, random cortical fields were ob-
vein and nerve supplying each kidney, were carefully served using a 	20 objective [41]. A graticule grid (25
squares) was used to determine the number of line inter-isolated.
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sects involving tubular profiles. One hundred intersec- antibody). Positive controls for iNOS binding were
performed on sections of kidney obtained from rats sixtions were examined for each kidney and a score from
0 to 3 was given for each tubular profile involving an hours after administration of lipopolysaccharide (LPS,
6 mg/kg, IV).intersection: 0 normal histology; 1 tubular cell swell-
ing, brush-border loss, nuclear condensation, with up to
Immunohistochemical localization of nitrotyrosine1/3 of tubular profile showing nuclear loss; 2  same for
score 1, but greater than 1/3 and less than 2/3 of the Tyrosine nitration, which was used as an index of the
nitrosylation of protein by peroxynitrite, was determinedtubular profile shows nuclear loss; 3  greater than 2/3
of tubular profile shows nuclear loss. The total score for using immunohistochemistry as previously described [46].
Briefly, sections were incubated overnight with a 1:1000each kidney was calculated by addition of all 100 scores
with a maximum score of 300. dilution of primary anti-nitrotyrosine monoclonal anti-
body (DBA). Separate sections also were incubated with
Immunohistochemical analysis of P-selectin control solutions consisting of PBS alone or a 1:500 dilu-
tion of non-specific purified rabbit IgG (DBA). SpecificImmunohistochemical localization of P-selectin in kid-
ney sections was performed as previously described [44]. labeling was detected using a biotin-conjugated goat
anti-rabbit IgG (DBA) and avidin-biotin peroxidaseBriefly, sections were fixed in 10% (wt/vol) PBS-buffered
formalin, permeabilized using 0.1% (vol/vol) Triton X-100 (DBA). Samples were then viewed under a light micro-
scope.in PBS for 20 minutes and incubated in 2% (vol/vol)
normal rat serum (DBA, Milan, Italy) for two hours
Measurement of myeloperoxidase activityto minimize non-specific adsorption. Sections were then
incubated overnight at 4C with rabbit anti-human poly- Myeloperoxidase (MPO) activity in kidneys was used
as an indicator of PMN infiltration into renal tissuesclonal antibody directed against P-selectin (DBA). Con-
trols included kidney sections incubated with buffer using a method previously described [41, 45]. Briefly, at
the end of the experiments, kidney tissue was weighedalone or non-specific purified IgG (DBA). After block-
ing endogenous avidin and biotin, specific labeling of and homogenized in a solution containing 0.5% (wt/vol)
hexadecyltrimethylammonium bromide dissolved in 10antigen-antibody complex was visualized using an avi-
din-biotin peroxidase complex immunoperoxidase tech- mmol/L potassium phosphate buffer (pH 7.4) and centri-
fuged for 30 minutes at 20,000 	 g at 4C. An aliquotnique using chromogen diaminobenzidine.
of supernatant was then removed and added to a reaction
Immunohistochemical analysis of inducible nitric oxide mixture containing 1.6 mmol/L tetramethylbenzidine
synthase expression and 0.1 mmol/L hydrogen peroxide. The rate of change
in absorbance was measured spectrophotometrically atThe expression of iNOS protein in renal sections was
evaluated using an immunohistochemical protocol de- 650 nm. MPO activity was defined as the quantity of
enzyme required to degrade 1 mol of hydrogen perox-scribed previously [45]. At the end of the experiment,
kidneys were bisected, snap-frozen in liquid nitrogen and ide at 37C and was expressed in mIU/100 mg wet tissue.
stored at 
70C. When required, samples were thawed,
Determination of malondialdehyde levelsdehydrated using graded ethanol and embedded in Para-
plast, after which 8 m sections were cut. After deparaf- Levels of malondialdehyde (MDA) in kidneys were
determined as an indicator of lipid peroxidation follow-finization, endogenous peroxidase was quenched using
0.3% (vol/vol) hydrogen peroxide in 60% (vol/vol) meth- ing a protocol described previously [41, 45]. Briefly, kid-
ney tissue was weighed and homogenized in a 1.15%anol for 30 minutes. Sections were permeablized using
0.1% (vol/vol) Triton X-100 in PBS for 20 minutes. Non- (wt/vol) KCl solution. A 100 L aliquot of homogenate
was then removed and added to a reaction mixture con-specific adsorption was minimized by incubating the sec-
tion in 2% (vol/vol) normal goat serum (DBA) in PBS taining 200 L 8.1% (wt/vol) lauryl sulfate, 1.5 mL 20%
(vol/vol) acetic acid, 1.5 mL 0.8% (wt/vol) thiobarbituricfor 20 minutes. Sequential incubation for 15 minutes with
avidin and biotin (DBA) was used to block endogenous acid and 700L distilled water. Samples were then boiled
for one hour at 95C and centrifuged at 3000 	 g for 10binding sites. The sections were then incubated overnight
with 1:1000 dilution of primary antibody against iNOS minutes. The absorbance of the supernatant was mea-
sured spectrophotometrically at 650 nm. MDA levels(DBA) or with control solutions. Controls included
buffer alone or non-specific purified rabbit IgG (DBA). were expressed as mol/L MDA/100 mg wet tissue.
Specific labeling was detected with a biotin-conjugated
Measurement of plasma nitrite/nitrate concentrationsgoat anti-rabbit IgG (DBA) and avidin-biotin peroxi-
dase complex (DBA). To verify the binding specificity Nitrite and nitrate are the primary oxidation products
of NO reacting with oxygen and, therefore, the nitrite/for iNOS (negative controls), some sections also were
incubated with only the secondary antibody (no primary nitrate concentration in plasma was used as an indicator
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of NO synthesis and was measured as described pre- RESULTS
viously [46]. Blood was collected into heparin-treated The mean  SEM for the weights of the rats used in
microcentrifuge tubes and centrifuged (6000 r.p.m. for this study was 271  4 g, N  78). On comparison with
3 min) to separate cells and plasma. Nitrate in the plasma Sham animals, renal I/R produced significant increases
sample was then enzymatically converted to nitrite. in serum and urinary markers of renal and tubular dys-
Briefly, nitrate was stoichiometrically reduced to nitrite function and tubular and reperfusion injury as described
by incubation of the sample aliquot (50 L) for 15 min- in detail later in this article. Renal I/R (with or without
utes at 37C in the presence of nitrate reductase (0.1 tempol), either alone or subsequent to pretreatment with
IU/mL, E.C. 1.6.6.2; Roche Diagnostics Ltd., Lewes, East LPS or LTA, did not have a significant effect on urine
Sussex, UK), -nicotinamide adenine dinucleotide phos- flow (0.017  0.001 mL/min, N  78).
phate (-NADPH; 50 mol/L) and flavin adenine di-
Effect of LPS or LTA pretreatment on renalnucleotide (FAD; 50 mol/L) in a final volume of 80
dysfunction mediated by I/RL. When the nitrate reduction was complete, unused
-NADPH, which interferes with the subsequent nitrite Animals that underwent renal I/R exhibited significant
determination, was oxidized by lactate dehydrogenase increases in the serum concentrations of creatinine com-
(LDH, 100 IU/mL; Roche) and sodium pyruvate (100 pared to Sham-operated animals (Fig. 1A), suggesting
mmol/L) in a final reduction volume of 100 L and incu- a significant degree of renal dysfunction. Compared to
bated for five minutes at 37C. Subsequently, total nitrite Control animals (I/R-only), pretreatment of rats with
in the plasma was assayed by adding 100 L Griess either LPS or LTA one hour prior to renal I/R did not
reagent [0.05% (wt/vol) naphthalethylenediamine dihy- produce any changes in serum levels of creatinine (Fig.
drochloride and 0.5% (wt/vol) sulphanilamide in 2.5% 1A). However, on comparison with control animals, 24
(vol/vol) phosphoric acid] to each sample. Optical den- hour pretreatment with LPS or LTA produced modest,
sity at 550 nm (OD550) was measured using a Molecular but significant, reductions in the serum levels of creati-
Devices microplate reader (Richmond, CA, USA). Total nine (Fig. 1A). The reductions in serum creatinine ob-
nitrite/nitrate concentration for each sample was calcu- tained after pretreatment of rats with LPS or LTA were
lated by comparison of the OD550 of a standard solution not significantly different from one another. Administra-
of sodium nitrate (also stoichiometrically converted to tion of saline (vehicle for LPS and LTA) to rats 1 or 24
nitrite) prepared in saline. hours prior to renal I/R did not result in any significant
alterations of serum levels of creatinine compared to
Materials Control animals (Fig. 1A).
Unless otherwise stated, all compounds used in this
Effect of LPS or LTA pretreatment on tubularstudy were purchased from Sigma-Aldrich Company
dysfunction mediated by I/RLtd. (Poole, Dorset, UK). All stock solutions were pre-
pared using non-pyrogenic saline (0.9% wt/vol NaCl; Renal I/R produced a significant increase in FENa (Fig.
Baxter Healthcare Ltd., Thetford, Norfolk, UK). The 1B), suggesting a marked increase in tubular dysfunction.
LTA used in this study was from S. aureus (Sigma) On comparison with FENa measured in Control animals,
whereas LPS was obtained from E. coli serotype 0.127:B8 administration of LPS or LTA one hour prior to renal
(Sigma). I/R did not have a significant effect on FENa (Fig. 1B).
However, pretreatment of rats with LPS or LTA 24
Statistical analysis hours prior to renal I/R produced significant reductions
All values described in the text and figures are ex- in FENa, suggesting improvement in tubular function (Fig.
pressed as mean standard error of the mean (SEM) for 1B). The reductions in FENa obtained were not signifi-
N observations. Each data point represents biochemical cantly different between the LTA and LPS pretreated
measurements obtained from up to six separate animals. groups (Fig. 1B). Administration of saline to rats 1 or
For histological scoring, each data point represents anal- 24 hours prior to renal I/R did not significantly alter FENa
ysis of kidneys taken from six individual animals. For compared with Control animals (Fig. 1B).
immunohistochemical analysis, the figures shown are
Effect of LPS or LTA pretreatment on I/R-mediatedrepresentative of at least three experiments performed
tubular and reperfusion-injuryon different experimental days. Statistical analysis was
carried out using GraphPad Prism 3.02/Instat 1.1 (Graph- On comparison with values obtained from Sham-oper-
Pad Software, San Diego, CA, USA). Data were ana- ated animals, renal I/R produced significant increases in
lyzed using one-way ANOVA followed by Dunnett’s the urinary levels of NAG (suggesting significant tubular
post hoc test and a P value of less than 0.05 was consid- injury; Fig, 2A) and serum concentrations of AST (sug-
gesting significant reperfusion-injury; Fig. 2B). Urinaryered to be significant.
Chatterjee et al: LTA reduces renal I/R injury1254
Fig. 2. LPS/LTA pretreatment and I/R-mediated tubular and reperfu-Fig. 1. Lipopolysaccharide (LPS)/lipoteichoic acid (LTA) pretreat-
sion injury. Effects of renal I/R on (A ) urinary N-acetyl--d-glucosami-ment and ischemia/reperfusion (I/R)-mediated renal and tubular dys-
nidase (NAG) concentrations and (B ) serum aspartate aminotransfer-function. Alterations in (A ) serum creatinine concentrations and (B )
ase (AST) levels after 1 or 24 hours pretreatment with saline (SAL, 2fractional excretion of Na (FENa) subsequent to renal I/R after pre-
mL/kg), LPS (1 mg/kg IP) or LTA (1 mg/kg IP). *P  0.05 vs. controltreatment for 1 or 24 hours with saline (SAL, 2 mL/kg IP), LPS (1
group (I/R only), P  0.05 vs. SAL 24-hour pretreatment group.mg/kg IP) or LTA (1 mg/kg IP). *P  0.05 vs. control group (I/R only),
P  0.05 vs. SAL 24-hour pretreatment group.
Effects of LPS or LTA pretreatment on renal
histopathology and scoringNAG and serum AST concentrations were not signifi-
cantly affected by pretreatment with LPS or LTA one On comparison with the normal renal histology ob-
hour prior to I/R (Fig. 2), but were significantly reduced served in kidneys taken from Sham-operated rats (Fig.
subsequent to the 24 hour pretreatment with LPS or 3A), animals that underwent renal I/R demonstrated the
LTA prior to renal I/R (Fig. 2). In each case, similar recognized features of tubular damage (Fig. 3B). These
reductions in either urinary NAG or serum AST were features included tubular dilation, brush border loss, nu-
obtained after pretreatment with LPS or LTA (Fig. 2). clear condensation, cytoplasmic swelling and consistent
Administration of saline to rats 1 or 24 hours prior to loss of significant numbers of nuclei from tubular profiles
I/R did not result in any significant alterations in urinary (Fig. 3B). Kidneys obtained from rats pretreated with
NAG or serum levels of AST compared to Control ani- LPS or LTA 24 hours prior to renal I/R demonstrated
reduced histological features of renal injury on compari-mals (Fig. 2).
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Fig. 3. Histological evaluation of renal I/R injury subsequent to pre-
treatment with LPS or LTA. Rats were subjected to (A ) Sham operation
(B ) I/R only (control group), or 24-hour pretreatment with (C ) LPS
(1 mg/kg IP) or (D ) LTA (1 mg/kg IP) followed by renal I/R. Sections
stained with trichromic Van Gieson (magnification 	400). (E ) Total
severity score; (out of a total score of 300) obtained from renal sections
from rats pretreated for 1 or 24 hours prior to renal I/R with either
saline (SAL, 2 mL/kg), LPS or LTA. Please refer to Methods section
for an explanation of the scoring system. *P  0.05 vs. control group,
P  0.05 vs. SAL 24-hour pretreatment group.
son with kidneys obtained from control animals (Fig. 3 kidneys obtained from Sham-operated animals, renal I/R
produced a significant increase in total severity scoreC, D). Markedly reduced tubular cell loss and tubular
dilation was observed in kidneys obtained from LPS or (Fig. 3E). Administration of LPS or LTA one hour prior
to renal I/R did not have a significant effect on totalLTA pretreated animals (Fig. 3 C, D).
Compared with the total severity score measured from severity score when compared to that obtained from
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Fig. 4. Immunohistochemical localization of P-selectin in rat kidney sections. (A ) Sham-operated group, (B ) Control group (I/R only), and 24-
hour pretreatment with (C ) LPS (1 mg/kg IP) or (D ) LTA (1 mg/kg IP) followed by renal I/R. Sections were incubated with rabbit anti-human
polyclonal antibody directed at P-selectin and specific labeling of antigen-antibody complex visualized using an avidin-biotin peroxidase complex
immunoperoxidase technique using chromogen diaminobenzidine. Magnification 	125.
Control animals (Fig. 3E). However, the total severity Effect of LPS and LTA pretreatment on kidney
myeloperoxidase activity and malondialdehyde levelsscore was significantly reduced by pretreatment with ei-
ther LPS or LTA 24 hours prior to renal I/R (Fig. 3E). Rats subjected to renal I/R exhibited a substantial
Administration of saline to rats 24 hours prior to renal increase in kidney MPO activity (Fig. 5A), suggesting
I/R did not have a significant effect on total severity increased PMN infiltration into renal tissues. However,
score when compared to that obtained from Control pretreatment of rats with LPS or LTA 24 hours prior to
animals (Fig. 3E). I/R produced a significant reduction of MPO activity on
comparison with MPO activity obtained from Control
Effect of LPS and LTA pretreatment on P-selectin rat kidneys (Fig. 5A). MPO activities obtained from rats
expression subsequent to renal I/R pretreated with LPS or LTA were not significantly differ-
Kidneys obtained from rats subjected to I/R demon- ent from one another (Fig. 5A) and both MPO activities
strated marked staining for P-selectin when compared were not significantly different from MPO activity mea-
with kidneys obtained from Sham-operated rats (Fig. 4 sured from kidneys obtained from Sham animals (Fig. 5A).
A, B), suggesting adhesion molecule expression during Rats subjected to renal I/R exhibited a substantial
reperfusion. Kidneys obtained from rats pretreated with increase in kidney MDA levels (Fig. 5B), suggesting in-
LPS or LTA demonstrated markedly reduced staining creased formation of reactive oxygen species (ROS) and
for P-selectin (Fig. 4 C, D) when compared with kidneys consequent lipid peroxidation. However, pretreatment
obtained from Control animals, suggesting a reduction of rats with LPS or LTA 24 hours prior to renal I/R
produced a significant reduction in MDA levels on com-in the expression of P-selectin during reperfusion.
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Fig. 5. Effects of LPS/LTA pretreatment followed by renal I/R on (A )
kidney myeloperoxidase (MPO) activity and (B ) kidney malondialde-
hyde (MDA) levels after 24 hours of pretreatment with LPS (1 mg/kg
IP) or LTA (1 mg/kg IP). *P  0.05 vs. control group (I/R only); P
 0.05 vs. LTA pretreatment group.
Fig. 6. Effects of tempol on LPS/LTA pretreatment and I/R-mediated
renal and tubular dysfunction. Alterations in (A ) serum creatinine
concentrations and (B ) fractional excretion of Na subsequent to renal
I/R after pretreatment for 24 hours with LPS (1 mg/kg IP) only, LPSparison with MDA levels obtained from Control rat kid-
(1 mg/kg) followed by tempol (30 mg/kg IV bolus injection followed
neys (Fig. 5B). MDA levels obtained from rats pre- by infusion of 30 mg/kg/h throughout the reperfusion period), LTA (1
mg/kg IP) only, LTA (1 mg/kg) followed by tempol (30 mg/kg IV bolustreated with LTA were significantly lower than that
injection followed by infusion of 30 mg/kg/h throughout the reperfusionobtained after pretreatment with LPS, suggesting a
period), or tempol only (30 mg/kg IV bolus injection followed by infu-
greater effect on lipid peroxidation and ROS production sion of 30 mg/kg/h throughout the reperfusion period). *P  0.05 vs.
control group (I/R only).(Fig. 5B).
Comparison of the effects of tempol and LPS or LTA
pretreatment on renal I/R Effects of LPS or LTA pretreatment on expression of
Administration of tempol to rats during renal I/R pro- iNOS and NO production
duced a significant reduction in both serum creatinine When compared to kidney sections obtained from
levels and FENa in comparison with values obtained from Sham-operated rats (Fig. 7A), immunohistochemical
Control animals (Fig. 6), suggesting improvement of re- analysis of sections obtained from rats subjected to renal
nal and tubular dysfunction. Tempol, when administered I/R revealed positive staining for iNOS (Fig. 7B). In
to rats pretreated with LPS or LTA, did not provide any contrast, reduced staining was observed in the kidney
additional improvement of serum creatinine levels or sections obtained from rats administered LPS (Fig. 7C)
FENa in comparison with levels obtained from rats pre- and substantially reduced staining was observed in kid-
ney sections obtained from rats pretreated with LTA 24treated with LPS or LTA only (Fig. 6).
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Fig. 7. LPS/LTA pretreatment and renal I/R-mediated iNOS expres-
sion. Kidney sections were incubated overnight with 1:1000 dilution of
primary antibody directed against iNOS. (A) Sham operation, (B) I/R-
only (control group), and 24-hour pretreatment with (C ) LPS (1 mg/kg
IP) or (D ) LTA (1 mg/kg IP) prior to renal I/R. Magnification: 	125.
(E ) Plasma nitrite/nitrate concentrations. Griess assay performed on
plasma collected from rats 1 or 24 hours after pretreatment with saline
(SAL, 2 mL/kg), LPS (1 mg/kg IP) or LTA (1 mg/kg IP). *P  0.05 vs.
control group (I/R only), P  0.05 vs. SAL 24-hour pretreatment
group, P  0.05 vs. sham-operated group.
hours prior to renal I/R (Fig. 7D). The positive control observed in kidney sections from rats subjected to renal
I/R, which were incubated with the secondary antibodyfor iNOS staining, performed on sections of kidneys ob-
tained from rats subjected to endotoxemia, demon- only (no primary antibody; negative control; data not
shown).strated marked positive staining for iNOS protein (data
not shown). No positive staining for iNOS protein was Renal I/R resulted in a significant increase in the
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plasma levels of nitrite/nitrate (an indicator of the forma- be involved in the protection afforded by 24 hours of
pretreatment of rats with LTA. Our study found thattion of NO) in comparison with values obtained from the
plasma of Sham-operated animals (Fig. 7E). Increased the renoprotective effects of LTA were time-dependent,
that is, one hour of pretreatment did not afford protec-plasma nitrite/nitrate levels mediated by renal I/R were
not significantly affected by pretreatment with LTA or tion but 24 hours was required for protection to be con-
ferred, suggesting a modulation of gene expression.LPS one hour prior to I/R, but were significantly reduced
subsequent to 24 hours of pretreatment with LPS or After 24 hours of pretreatment with LTA: (1) expression
of the adhesion molecule P-selectin caused by renal I/RLTA prior to renal I/R (Fig. 7E). In each case, similar
reductions in either plasma nitrite/nitrate levels were was reduced; (2) renal MPO activity was reduced to
levels observed from Sham-operated animals, suggestingobtained after pretreatment with LTA or LPS (Fig. 7E).
However, plasma nitrite/nitrate levels obtained rats pre- a reduction in PMN infiltration into renal tissues; (3)
reduced renal MDA levels were observed, suggestingtreated with LPS or LTA and subjected to renal I/R
were still significantly higher than levels obtained from decreased lipid peroxidation due to reduced production
of ROS; (4) a reduction in the expression of iNOS andSham-operated animals (Fig. 7E). Administration of sa-
line only to rats 1 or 24 hours prior to I/R did not result NO production (compared to I/R-only rats) was found;
and (5) there was evidence of reduced nitrotyrosine for-in any significant alterations of plasma levels of nitrite/
nitrate compared to Control animals (Fig. 7E). mation, indicating reduced peroxynitrite production.
Further studies found that the protective effects of LTA
Effect of LPS or LTA on nitrotyrosine formation against renal and tubular dysfunction were comparable
during renal I/R to that obtained using tempol, a ROS-scavenger that
removes both superoxide and hydroxyl radicals, whichIn comparison to renal sections obtained from Sham-
operated rats that were administered saline only (Fig. we have previously shown to provide beneficial actions
against renal I/R injury in the rat [41]. Additive effects8A), immunohistochemical analysis of renal sections ob-
were not observed when tempol was administered to ratstained from rats subjected to renal I/R revealed positive
pretreated with LTA, indicating that LTA pretreatmentstaining for nitrotyrosine (Fig. 8B). In contrast, substan-
was effective in reducing the formation of ROS (as re-tially reduced nitrotyrosine staining was observed in the
flected in the ability of LTA pretreatment to reduce lipidkidney sections obtained from rats, which were pre-
peroxidation to levels not significantly different fromtreated with LPS (Fig. 8C) or LTA (Fig. 8D) 24 hours
Sham-operated animals). Finally, although iNOS expres-prior to renal I/R.
sion was substantially reduced and NO production sig-
nificantly attenuated by pretreatment with LTA, levels of
DISCUSSION nitrite/nitrate in the plasma remained significantly higher
Renal I/R is a common problem that occurs during than those measured in the plasma of Sham-operated
aortic surgery or renal transplantation or is caused by animals. Thus, we propose that the beneficial actions of
cardiovascular anesthesia, leading to renal dysfunction LTA pretreatment are mediated by a significant reduc-
and injury [4, 5, 47–50]. Thus, early therapeutic interven- tion in the production of ROS, NO and peroxynitrite.
tion that reduces the consequences of renal I/R has been However, we propose that the significant levels of NO
a topic of intense research interest, motivated by the fact production measured after renal I/R contribute to the
that previous interventions against ARF have proven to beneficial actions of LTA, a hypothesis discussed in de-
be largely negative and that dialysis still remains the only tail in the next section.
effective therapy [1]. To date, preconditioning of the
LTA pretreatment reduces adhesion moleculekidney (whether ischemic, hypoxic, chemical or by heat-
expression, PMN infiltration and production of ROSshock) has generally provided a greater degree of protec-
tion against renal I/R injury than most other pharmaco- In this study, LTA pretreatment markedly reduced
logical interventions [7]. The results presented here the expression of P-selectin, the expression of which,
demonstrate, to our knowledge for the first time, that 24 among other adhesion molecules, has been associated
hour pretreatment (or pharmacological preconditioning) with renal I/R-injury [51, 52]. Several studies have dem-
with a non-lethal dose of LTA (1 mg/kg) significantly onstrated that P-selectin is expressed during renal I/R
reduces the renal and tubular dysfunction, and tubular and ARF, and ligands that block P-selectin or antibody
and reperfusion injury associated with a subsequent epi- directed against P-selectin can reduce renal I/R injury
sode of I/R of the rat kidney. Furthermore, LTA pre- [53]. Expression of adhesion molecules such as P-selectin
treatment produced a marked reduction in the histologi- and intercellular adhesion molecule (ICAM)-1 is a fun-
cal evidence of renal injury including tubular dilatation damental requirement for the recruitment of PMNs into
and congestion. renal tissues during renal reperfusion [51–53] and studies
using specific markers of PMNs indicate their accumula-It is interesting to consider the mechanism(s) that may
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Fig. 8. LPS/LTA pretreatment and renal I/R-mediated nitrotyrosine formation. Kidney sections were incubated overnight with 1:1000 dilution of
primary antibody directed against nitrotyrosine. (A ) Sham operation, (B ) I/R only (control group), and 24 hours of pretreatment with (C ) LPS
(1 mg/kg IP) or (D ) LTA (1 mg/kg IP) prior to renal I/R. Magnification 	125.
tion in postischemic kidneys [54, 55]. Our current study tion of PMN infiltration into renal tissues was reflected
by a significant reduction in MDA levels in the kidneysshowed that LTA pretreatment reduced renal MPO ac-
tivity to levels that were not significantly different to of rats pretreated with LTA (almost to levels measured
in renal tissues obtained from Sham-operated rats), sug-levels measured in the kidneys of Sham-operated rats,
suggesting an almost total reduction in PMN infiltration gesting significant reduction in lipid peroxidation (subse-
quent to reduced production of ROS).into renal tissues. This finding is in keeping with previous
studies reporting that depletion of PMN activity or num- Taken together, the evidence presented in our study
suggests that renal I/R produces moderate glomerularbers reduces renal I/R injury [52, 54, 55]. Activated
PMNs are generally considered to be the principal ef- dysfunction, but a substantial increase in tubular dys-
function and injury. This is in keeping with the notionfectors of renal I/R-injury as they can release (1) super-
oxide, which can be converted to hydroxyl radicals and that renal I/R causes both glomerular and tubular dys-
function [57]. Several reports have described the vulnera-(2) NO, which can combine with superoxide to form
peroxynitrite (see below) [56]. Hydroxyl radicals and bility of the outer medulla and thick ascending limb cells
to structural damage during renal I/R, which has beenperoxynitrite are highly reactive and cause tissue injury,
for example, via lipid peroxidation, DNA damage and attributed to the imbalance between the metabolic de-
mand of this region of the kidney and oxygen deliveryactivation of poly (ADP-ribose) polymerase [42, 52, 54–
56]. PMNs also release myeloperoxidase, which catalyses to these cells [58]. Although not directly investigated in
our study, distribution of PMNs in the cortex, outer andthe formation of another potent oxidant, hypochlorous
acid [56]. PMNs also generate cytokines and interact inner medulla during I/R previously has been investi-
gated, and after two hours of reperfusion a gradient ofwith the renal endothelium leading to further pathophys-
iology [21]. In this study, the beneficial role of attenua- PMN accumulation has been described (cortex  outer
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medulla inner medulla) [59]. After a two-hour reperfu- or presence of peroxynitrite (such as using ebselen) [41,
46, 69]. In our current study, LTA pretreatment mark-sion, the outer medulla contains very few PMNs and in
the cortex itself, the peritubular regions contain double edly reduced nitrotyrosine formation, which is indicative
of peroxynitrite production, presumably via inhibitionthe numbers of PMNs compared to intraglomerular re-
gions. However, although it is important to consider the of superoxide anion and reduction of NO production.
Heeman and colleagues demonstrated the beneficialrole of the medulla during episodes of renal I/R where
it has been reported that PMNs may contribute indirectly actions of LPS pretreatment against renal I/R injury in
mice [19], while IL-1, interferon (IFN)- and iNOSto tubular injury by exacerbating medullary hypoperfu-
sion during reperfusion [58, 60], it is also accepted that mRNA expression did not change during the pretreat-
ment and reperfusion periods. However, increased TNF-PMNs play an important role in direct injury to the
tubular injury associated with renal reperfusion [51, 60]. (2 hours after reperfusion) and decreased IL-6 (before
ischemia and shortly after commencement of reperfu-Furthermore, early observations have reported that the
damage to kidney during I/R is primarily to the S3 seg- sion) mRNA expression were observed and reported as
potential mechanisms for the observed beneficial effectsment of the PT [61]. This was further reinforced by
the demonstration in our study that renal I/R caused [19]. Although we did not study this in the rats here, the
ability of LTA to modulate cytokine production certainlyrelatively greater tubular dysfunction and injury than
glomerular dysfunction and that the beneficial effects of warrants further investigation.
Our results showed that LTA provided beneficial ac-LTA pretreatment were more pronounced on tubular
dysfunction and injury (FENa and urinary NAG). How- tions that were not significantly different to those ob-
tained using LPS. However, a major advantage of usingever, we are confident that the effects of LTA on adhe-
sion molecule expression (observed in the cortex) and LTA at the concentration used is that it did not produce
any of the obvious ‘endotoxic’ side-effects associatedon PMN recruitment (measured as MPO activity) will
also prevail in medullary regions. with a similar administration of LPS, mediated by exces-
sive generation of pro-inflammatory cytokines, induction
LTA pretreatment reduces iNOS expression, NO of pro-inflammatory genes and release of mediators of
production and peroxynitrite formation cellular injury [20, 21]. This advantage of LTA adminis-
tration over LPS is reflected in our earlier studies inIn this study, LTA pretreatment markedly reduced
the I/R-mediated expression of iNOS in the rat kidney which LPS pretreatment (1 mg/kg) activated the coagula-
tion cascade and caused liver injury in the rat [37]. In rats,and subsequently, plasma nitrite/nitrate levels, indicating
reduced NO production. There is now good evidence higher doses of LTA (10 mg/kg) causes only a moderate
induction of iNOS and hypotension in the rat, withoutthat formation of high levels of NO subsequent to the
expression of iNOS plays an important role in the patho- producing the multiple organ failure or death [31, 33].
Additionally, it has also been shown that—unlike LPS—physiology of renal injury mediated by hypoxia and I/R
of the kidney [46, 60, 62]. NO mediates cytotoxicity via LTA administered at 10 mg/kg to rats does not induce
iNOS in the kidney [35] and does not cause renal in-several mechanisms including DNA damage, inhibition
of mitochondrial respiration and degradation of the actin flammation [34], even though in mice it localizes to the
kidney 24 hours after administration, producing highcytoskeleton as well as by modulation of the expression
of cytokines and adhesion molecules [60, 62]. Several local concentrations [36].
studies by our and other laboratories have shown that
Role of NO in the protection against renal I/R injuryinhibition of the expression or activity of iNOS, or the
afforded by LTA pretreatmentabsence of iNOS itself can ameliorate or prevent renal
I/R injury [46, 63, 64]. We demonstrate here that LTA Although LTA pretreatment substantially reduced
iNOS expression and significantly attenuated NO pro-pretreatment is associated with a marked reduction in
iNOS expression and subsequent NO production, and duction subsequent to renal I/R, plasma levels of NO
remained significantly higher than levels measured inpropose that this contributes to the observed renoprotec-
tive actions of LTA. Furthermore, NO reacts with super- the plasma of Sham-operated rats (Fig. 7E). The benefi-
cial role of NO in preconditioning of the kidney, brainoxide anion to form the highly reactive and injurious
species peroxynitrite [65], which causes injury via direct and heart been well been characterized [7, 70–72]. In
the heart and brain, a biphasic response has been de-oxidant injury and protein tyrosine nitration, as well as
via the production of hydroxyl radicals [66, 67]. Specifi- scribed in which NO from eNOS is utilized as an immedi-
ate but short-term response, and NO from iNOS as acally in the kidney, peroxynitrite generation is implicated
in the pathophysiology of both renal I/R and hypoxia- delayed but long-term defense [71, 72]. Ogawa and col-
leagues recently demonstrated that NO, produced fromreoxygenation injury, respectively [41, 46, 60, 62, 68],
and recent studies by our group and others have demon- eNOS, mediated ischemic preconditioning of the kidney,
which could be blocked using N-nitro-l-arginine methylstrated the beneficial actions of inhibiting the formation
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